Multi-User High Throughput Flow Cytometry System

多用户高通量流式细胞仪系统

• 批准号: RTI-2022-00303
• 负责人: Rahim, MirMunir
• 金额: $ 10.71万
• 依托单位: University of Windsor
• 依托单位国家: 加拿大
• 项目类别: Research Tools and Instruments
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-01-01 至 2022-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=743052
• 关键词: Multi; User; Throughput; Flow; Cytometry

Flow cytometry is a staple technique which provides state-of-the art analysis of the characteristics of cells and particles. The Windsor-Essex region has over $30M in research funding and a large base of productive NSERC funded faculty which depend on this technology. An initial ~$1M investment by CFI in 2015 funded the purchase of two machines, a BD FACSAria III Fusion Cell Sorter and a BD LSR Fortessa X20 Cell Analyzer, which function as work horses to support the flow cytometry needs in this region. There is literally no other back up option for these researchers. This proposal is toward adding to this equipment to include high throughput modules that will speed up processing, allow for small sample volumes to be used and will alleviate some of the technical time spent running the machine by our PhD level core manager. This application also includes an update to the software for these machines which will provide a remote portal license that permits students and trainees to analyze their data on their own computers, thereby elevating the quality of their learning and opening up the machines for sample processing by other users. Acquiring modules to upgrade this facility to be capable of sorting and analyzing small volume samples in a high throughput manner will enable new types of experiments and analysis to be conducted within the Windsor region. This will elevate the training experience for many students and will propel up to 22 NSERC funded labs forward within the first few years after purchase. This investment will also bring new users to the facility, increasing the reach of this investment and supporting the long-term viability of these important machines.

流式细胞术是一种主要技术，可提供细胞和颗粒特征的最新分析。温莎-埃塞克斯地区拥有超过3000万美元的研究资金和大量依靠这项技术的NSERC资助的教师。CFI在2015年的初始投资约为100万美元，用于购买两台机器，一台BD FACSAria III融合细胞分选仪和一台BD LSR Fortessa X20细胞分析仪，作为支持该地区流式细胞术需求的工作马。对于这些研究人员来说，实际上没有其他的选择。该提案旨在为该设备添加高通量模块，以加快处理速度，允许使用小样本量，并减少我们的博士级核心经理运行机器所花费的一些技术时间。该应用程序还包括对这些机器的软件进行更新，该软件将提供远程门户许可证，允许学生和学员在自己的计算机上分析他们的数据，从而提高他们的学习质量，并开放机器供其他用户进行样品处理。获取模块以升级该设施，使其能够以高通量方式分选和分析小体积样品，将使新型实验和分析能够在温莎地区进行。这将提升许多学生的培训体验，并将在购买后的头几年内推动多达22个NSERC资助的实验室向前发展。这项投资还将为该设施带来新的用户，增加这项投资的覆盖范围，并支持这些重要机器的长期可行性。